By a News Reporter-Staff News Editor at South Korea Daily Report-- Investigators discuss new findings in Herpesvirus Diseases ...
CMV is the most common infectious cause of birth defects in the U.S.; there is no approved vaccine to prevent CMV CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage ...
Early interim data show Cytomegalovirus (CMV)-negative kidney transplant recipients vaccinated with three doses of HB-101 had reduced incidence of CMV viremia, reduced antiviral use and no CMV disease ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...
According to the epidemiologic data of the Vermont-Oxford database from 1997, 40 to 50% of preterm newborns delivered before 32 wk of gestation with a birth weight ≤1.500 g developed BPD, a chronic ...
In more than 95% of cases, CMV enters the immunocompetent host without causing any symptoms of infection, as it has developed numerous gene products that will evade or interfere with the immune ...
Early interim data show Cytomegalovirus (CMV)-negative kidney transplant recipients vaccinated with three doses of HB-101 had reduced incidence of CMV viremia, reduced antiviral use and no CMV disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results